Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing
The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine
Who this might be right for
Virus Diseases
GlaxoSmithKline 194